Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8219
Reference
MSAN(2024)43
Name
Quetiapine 150mg, 200mg, 300mg tablets – UPDATE
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
There are limited supplies of quetiapine 150mg, 200mg and 300mg tablets until late August 2024. Subject to short-term localised supply issues, quetiapine 25mg, 50mg and 100mg tablets currently remain available and can support a partial increase in demand. Quetiapine XL prolonged release tablets (50mg, 150mg, 200mg, 300mg, 400mg and 600mg) remain available and can support a partial increase in demand. Quetiapine 20mg/ml oral suspension remains available and can support a partial increase in demand. Any updates to the supply of quetiapine tablets (any strengths) will be communicated via the Specialist Pharmacy Service (SPS) Medicines Supply Tool. Serious Shortage Protocols (SSPs) for quetiapine 150mg, 200mg and 300mg tablets were issued on 16/07/2024. The SSPs are listed in the links to further information section.
Contact Name
Contact Email
Contact Address
Created
2024-07-24 09:38:00
Click to go back to homepage